Ignite Creation Date:
2025-12-24 @ 5:02 PM
Ignite Modification Date:
2026-02-02 @ 4:57 AM
Study NCT ID:
NCT00040950
Status:
COMPLETED
Last Update Posted:
2013-12-19
First Post:
2002-07-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Sponsor:
Jonsson Comprehensive Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Lymphoma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | recurrent grade 1 follicular lymphoma | View |
| None | recurrent grade 2 follicular lymphoma | View |
| None | recurrent grade 3 follicular lymphoma | View |
| None | recurrent adult diffuse small cleaved cell lymphoma | View |
| None | recurrent adult diffuse mixed cell lymphoma | View |
| None | recurrent adult diffuse large cell lymphoma | View |
| None | recurrent adult immunoblastic large cell lymphoma | View |
| None | recurrent adult lymphoblastic lymphoma | View |
| None | recurrent adult Burkitt lymphoma | View |
| None | recurrent mantle cell lymphoma | View |
| None | recurrent marginal zone lymphoma | View |
| None | recurrent small lymphocytic lymphoma | View |
| None | extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue | View |
| None | nodal marginal zone B-cell lymphoma | View |
| None | splenic marginal zone lymphoma | View |